1999
DOI: 10.1016/s0005-2736(99)00166-2
|View full text |Cite
|
Sign up to set email alerts
|

Insights into the structure and substrate interactions of the P-glycoprotein multidrug transporter from spectroscopic studies

Abstract: The P-glycoprotein multidrug transporter is a 170-kDa efflux pump which exports a diverse group of natural products, chemotherapeutic drugs, and hydrophobic peptides across the plasma membrane, driven by ATP hydrolysis. The transporter has been proposed to interact with its drug substrates within the membrane environment; however, much remains to be learned about the nature and number of the drug binding site(s). The two nucleotide binding domains are responsible for ATP binding and hydrolysis, which is couple… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1

Citation Types

12
72
0

Year Published

2001
2001
2014
2014

Publication Types

Select...
6
3

Relationship

1
8

Authors

Journals

citations
Cited by 100 publications
(87 citation statements)
references
References 85 publications
12
72
0
Order By: Relevance
“…An unresolved question concerns the role (if any) of Wzm itself in substrate recognition. Substrate-binding sites are located in the TMD component of many ABC efflux systems, with the eukaryotic multidrug transporter P-glycoprotein serving as a wellstudied example (24,25). The current data suggest that Wzm is not involved in O-PS specificity but does not rule out its possible recognition of features present in both O8 and O9a polymers.…”
Section: Discussionmentioning
confidence: 99%
“…An unresolved question concerns the role (if any) of Wzm itself in substrate recognition. Substrate-binding sites are located in the TMD component of many ABC efflux systems, with the eukaryotic multidrug transporter P-glycoprotein serving as a wellstudied example (24,25). The current data suggest that Wzm is not involved in O-PS specificity but does not rule out its possible recognition of features present in both O8 and O9a polymers.…”
Section: Discussionmentioning
confidence: 99%
“…However, several lines of evidence suggest that MRP1 and P-gp confer resistance to these drugs by different mechanisms. In vitro studies using P-gp-enriched membrane vesicles or purified reconstituted protein demonstrate that P-gp directly binds and transports its drug substrates in an ATP-dependent manner (11,12). Under similar conditions, MRP1 will only transport unmodified amphipathic drugs, such as vincristine and daunorubicin, in the presence of GSH in addition to ATP (13-17).…”
mentioning
confidence: 99%
“…5-HT is considered to increase the intracellular cAMP level via 5-HT receptors, but the possibility that chronic 5-HT depletion enhances trafficking cannot be excluded, as is the case for the intracellular Ca 2ϩ level. Moreover, phosphorylation and glycosylation of P-gp and membrane conditions where P-gp is located are suggested to be factors regulating the activity and expression of P-gp (Castro et al, 1999;Sharom et al, 1999;Gribar et al, 2000). Therefore, further investigation is needed to clarify the mechanisms behind the induction of P-gp expression in the brush-border membrane by 5-HT depletion.…”
Section: Discussionmentioning
confidence: 99%